EXTON, Pa. and GERMANTOWN, Md., Sept. 25, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (FCSC), an autologous cell and gene therapy company focused on developing first-in-class treatments for rare ...